Form 4 for RCEL AVITA Medical, Inc.
Accepted 2021-09-07 00:00:00 ET · period of report 2021-05-18 · accession 0001209191-21-054957 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-07 | 2021-07-06 | RCEL | Shiroma Donna | GC | A - Grant | — | +10.5K | 12.0K | +700% | — |
| DM | 2021-09-07 | 2021-05-18+ | RCEL | Shiroma Donna | GC | A - Grant | $0.00 | +11.3K | 6,925 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | A | A | 10,500 | — | 12,000 | D | — | — | (F1) Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of Restricted Stock Units. |
| 2 | Derivative | Stock Options (Right to Buy) | 2021-05-18 | A | A | 4,400 | $0.00 | 11,000 | D | $4.38 · — to 2028-06-25 | 4,400 Common Stock | (F2) These Stock Options were originally granted on June 25, 2018 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition. |
| 3 | Derivative | Stock Options (Right to Buy) | 2021-07-06 | A | A | 6,925 | $0.00 | 6,925 | D | $20.21 · — to 2031-07-06 | 6,925 Common Stock | (F3) These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options. |